Handelen Shattuck Labs, Inc. - STTK CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.18 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Shattuck Labs Inc ESG Risk Ratings
High Medium Low Negligible
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 2.71 |
| Open* | 2.77 |
| 1-Jaarlijkse Verandering* | 2.97% |
| Dagelijks bereik* | 2.67 - 2.82 |
| 52 wekelijks bereik | 1.85-5.82 |
| Weekgemiddelde volume (10 dagen) | 34.80K |
| Gemiddeld volume (3 maanden) | 827.68K |
| Marktkapitalisatie | 115.52M |
| P/E Ratio | -100.00K |
| Uitstaande Aandelen | 42.47M |
| Omzet | 709.00K |
| EPS | -2.31 |
| Dividend (opbrengst %) | N/A |
| Beta | -100.00K |
| Volgende inkomsten datum | Aug 9, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| May 30, 2023 | 2.71 | 0.01 | 0.37% | 2.70 | 2.79 | 2.69 |
| May 26, 2023 | 2.70 | -0.04 | -1.46% | 2.74 | 2.74 | 2.63 |
| May 25, 2023 | 2.75 | -0.16 | -5.50% | 2.91 | 2.91 | 2.63 |
| May 24, 2023 | 2.83 | 0.11 | 4.04% | 2.72 | 2.88 | 2.64 |
| May 23, 2023 | 2.75 | 0.23 | 9.13% | 2.52 | 2.80 | 2.52 |
| May 22, 2023 | 2.57 | -0.34 | -11.68% | 2.91 | 3.03 | 2.56 |
| May 19, 2023 | 2.63 | -0.05 | -1.87% | 2.68 | 2.68 | 2.63 |
| May 18, 2023 | 2.58 | 0.12 | 4.88% | 2.46 | 2.58 | 2.46 |
| May 17, 2023 | 2.47 | -0.06 | -2.37% | 2.53 | 2.53 | 2.43 |
| May 16, 2023 | 2.59 | 0.03 | 1.17% | 2.56 | 2.62 | 2.53 |
| May 15, 2023 | 2.59 | -0.02 | -0.77% | 2.61 | 2.61 | 2.58 |
| May 12, 2023 | 2.58 | -0.09 | -3.37% | 2.67 | 2.70 | 2.58 |
| May 11, 2023 | 2.78 | 0.20 | 7.75% | 2.58 | 2.79 | 2.58 |
| May 10, 2023 | 2.68 | -0.09 | -3.25% | 2.77 | 2.78 | 2.55 |
| May 8, 2023 | 2.67 | 0.04 | 1.52% | 2.63 | 2.74 | 2.53 |
| May 5, 2023 | 2.68 | -0.10 | -3.60% | 2.78 | 2.79 | 2.63 |
| May 4, 2023 | 2.78 | -0.01 | -0.36% | 2.79 | 2.79 | 2.78 |
| May 3, 2023 | 2.78 | -0.04 | -1.42% | 2.82 | 2.82 | 2.78 |
| May 2, 2023 | 2.87 | -0.12 | -4.01% | 2.99 | 2.99 | 2.82 |
| May 1, 2023 | 3.05 | 0.17 | 5.90% | 2.88 | 3.11 | 2.88 |
Shattuck Labs, Inc. Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| Wednesday, August 9, 2023 | ||
| Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q2 2023 Shattuck Labs Inc Earnings Release Q2 2023 Shattuck Labs Inc Earnings ReleaseForecast -Previous - |
| Monday, November 6, 2023 | ||
| Tijd (UTC) (UTC) 10:59 | Land US
| Evenement Q3 2023 Shattuck Labs Inc Earnings Release Q3 2023 Shattuck Labs Inc Earnings ReleaseForecast -Previous - |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale inkomsten | 0.652 | 30.017 | 9.934 | 9.887 | 22.442 |
| Inkomsten | 0.652 | 30.017 | 9.934 | 9.887 | 22.442 |
| Totale bedrijfskosten | 103.981 | 75.286 | 46.865 | 34.954 | 27.808 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 21.082 | 18.723 | 9.382 | 5.736 | 3.783 |
| Onderzoek & Ontwikkeling | 82.199 | 56.563 | 37.483 | 29.218 | 24.807 |
| Ongebruikelijke uitgaven (inkomsten) | 0.7 | 0 | -0.782 | ||
| Bedrijfsresultaat | -103.329 | -45.269 | -36.931 | -25.067 | -5.366 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 1.592 | 0.625 | 0.549 | 1.184 | -1.665 |
| Overige, Netto | -0.208 | -0.33 | -0.221 | -0.099 | -0.357 |
| Netto inkomen voor belastingen | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Netto inkomen na belastingen | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Netto inkomen voor extra. Posten | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Netto inkomen | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Verwaterd Netto Inkomen | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Verwaterd Gewogen Gemiddelde Aandelen | 42.3789 | 42.0324 | 41.7674 | 38.0795 | 38.0795 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -2.40556 | -1.06998 | -0.87635 | -0.62979 | -0.19401 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
| Verwaterde Genormaliseerde Winst per Aandeel | -2.38904 | -1.06998 | -0.87635 | -0.62979 | -0.21455 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 0.057 | 0.39 | 0.212 | 0.05 | 0 |
| Inkomsten | 0.057 | 0.39 | 0.212 | 0.05 | 0 |
| Totale bedrijfskosten | 21.718 | 26.666 | 25.441 | 27.708 | 24.166 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 5.051 | 4.779 | 6.579 | 4.745 | 4.979 |
| Onderzoek & Ontwikkeling | 16.667 | 21.987 | 18.462 | 22.563 | 19.187 |
| Bedrijfsresultaat | -21.661 | -26.276 | -25.229 | -27.658 | -24.166 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 1.592 | ||||
| Overige, Netto | 0.937 | -0.727 | 0.594 | 0.287 | -0.362 |
| Netto inkomen voor belastingen | -20.724 | -25.411 | -24.635 | -27.371 | -24.528 |
| Netto inkomen na belastingen | -20.724 | -25.411 | -24.635 | -27.371 | -24.528 |
| Netto inkomen voor extra. Posten | -20.724 | -25.411 | -24.635 | -27.371 | -24.528 |
| Netto inkomen | -20.724 | -25.411 | -24.635 | -27.371 | -24.528 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -20.724 | -25.411 | -24.635 | -27.371 | -24.528 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -20.724 | -25.411 | -24.635 | -27.371 | -24.528 |
| Verwaterd Netto Inkomen | -20.724 | -25.411 | -24.635 | -27.371 | -24.528 |
| Verwaterd Gewogen Gemiddelde Aandelen | 42.4392 | 42.3907 | 42.3865 | 42.3805 | 42.3576 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.48832 | -0.59945 | -0.5812 | -0.64584 | -0.57907 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Verwaterde Genormaliseerde Winst per Aandeel | -0.48832 | -0.60181 | -0.57176 | -0.6364 | -0.57907 |
| Ongebruikelijke uitgaven (inkomsten) | -0.1 | 0.4 | 0.4 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 184.584 | 288.266 | 345.639 | 42.442 | 65.634 |
| Geldmiddelen en kortetermijnbeleggingen | 161.28 | 268.804 | 335.449 | 39.087 | 60.376 |
| Geldmiddelen & Equivalenten | 47.379 | 92.268 | 157.898 | 7.013 | 31.644 |
| Korte Termijn Investeringen | 113.901 | 176.536 | 177.551 | 32.074 | 28.732 |
| Prepaid Expenses | 23.304 | 19.462 | 10.19 | 3.355 | 5.258 |
| Total Assets | 205.324 | 298.585 | 348.988 | 44.969 | 68.161 |
| Property/Plant/Equipment, Total - Net | 20.306 | 9.938 | 3 | 2.437 | 2.504 |
| Property/Plant/Equipment, Total - Gross | 26.015 | 12.718 | 4.48 | 3.299 | 2.856 |
| Accumulated Depreciation, Total | -5.709 | -2.78 | -1.48 | -0.862 | -0.352 |
| Other Long Term Assets, Total | 0.434 | 0.381 | 0.349 | 0.09 | 0.023 |
| Total Current Liabilities | 24.965 | 24.586 | 16.834 | 19.984 | 20.852 |
| Accounts Payable | 7.17 | 10.012 | 1.754 | 3.051 | 2.048 |
| Accrued Expenses | 17.795 | 14.574 | 7.352 | 4.039 | 1.76 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0 | 7.728 | 12.894 | 17.044 | |
| Total Liabilities | 29.167 | 26.799 | 39.127 | 30.453 | 30.178 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 4.202 | 2.213 | 22.293 | 10.469 | 9.326 |
| Total Equity | 176.157 | 271.786 | 309.861 | 14.516 | 37.983 |
| Redeemable Preferred Stock | 0 | 49.064 | 49.064 | ||
| Common Stock | 0.005 | 0.005 | 0.005 | 0.001 | 0.001 |
| Additional Paid-In Capital | 396.041 | 389.408 | 382.012 | 0.887 | 0.426 |
| Retained Earnings (Accumulated Deficit) | -219.012 | -117.067 | -72.093 | -35.49 | -11.508 |
| Other Equity, Total | -0.877 | -0.56 | -0.063 | 0.054 | 0 |
| Total Liabilities & Shareholders’ Equity | 205.324 | 298.585 | 348.988 | 44.969 | 68.161 |
| Total Common Shares Outstanding | 42.3906 | 42.3389 | 41.7674 | 38.0795 | 38.0795 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 157.837 | 184.584 | 201.516 | 229.417 | 254.988 |
| Geldmiddelen en kortetermijnbeleggingen | 135.495 | 161.28 | 185.114 | 214.24 | 239.225 |
| Geldmiddelen & Equivalenten | 66.043 | 47.379 | 39.758 | 37.87 | 50.743 |
| Korte Termijn Investeringen | 69.452 | 113.901 | 145.356 | 176.37 | 188.482 |
| Prepaid Expenses | 22.342 | 23.304 | 16.402 | 15.177 | 15.763 |
| Total Assets | 177.677 | 205.324 | 222.943 | 251.34 | 270.49 |
| Property/Plant/Equipment, Total - Net | 16.887 | 20.306 | 20.959 | 21.555 | 15.145 |
| Other Long Term Assets, Total | 2.953 | 0.434 | 0.468 | 0.368 | 0.357 |
| Total Current Liabilities | 16.009 | 24.965 | 19.139 | 24.245 | 16.814 |
| Accounts Payable | 5.128 | 7.17 | 3.036 | 5.674 | 2.593 |
| Accrued Expenses | 10.881 | 17.795 | 16.103 | 18.571 | 14.221 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | |||||
| Total Liabilities | 20.023 | 29.167 | 23.525 | 28.811 | 21.552 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 4.014 | 4.202 | 4.386 | 4.566 | 4.738 |
| Total Equity | 157.654 | 176.157 | 199.418 | 222.529 | 248.938 |
| Common Stock | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
| Additional Paid-In Capital | 397.724 | 396.041 | 394.348 | 392.598 | 391.055 |
| Retained Earnings (Accumulated Deficit) | -239.736 | -219.012 | -193.601 | -168.966 | -141.595 |
| Other Equity, Total | -0.339 | -0.877 | -1.334 | -1.108 | -0.527 |
| Total Liabilities & Shareholders’ Equity | 177.677 | 205.324 | 222.943 | 251.34 | 270.49 |
| Total Common Shares Outstanding | 42.4603 | 42.3906 | 42.3906 | 42.382 | 42.3785 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | -101.945 | -44.974 | -36.603 | -23.982 | -7.388 |
| Geldmiddelen uit Operationele Activiteiten | -94.498 | -57.116 | -33.659 | -20.975 | -6.903 |
| Geldmiddelen uit Operationele Activiteiten | 3.073 | 1.38 | 0.618 | 0.537 | 0.255 |
| Niet-Geldelijke Posten | 8.838 | 8.502 | 1.267 | 0.254 | 2.726 |
| Veranderingen in het Operationeel Kapitaal | -4.464 | -22.024 | 1.059 | 2.216 | -2.496 |
| Geldmiddelen uit Investeringsactiviteiten | 49.438 | -10.443 | -146.322 | -3.592 | -29.925 |
| Kapitaaluitgaven | -11.614 | -7.926 | -0.727 | -0.47 | -1.178 |
| Overige Cash Flow investeringsposten, Totaal | 61.052 | -2.517 | -145.595 | -3.122 | -28.747 |
| Geldmiddelen uit Financieringsactiviteiten | 0.171 | 1.929 | 330.866 | -0.064 | 35.145 |
| Financiering van Cash Flow Posten | 0 | -18.738 | -0.064 | -0.152 | |
| Uitgifte (Aflossing) van aandelen, netto | 0.171 | 1.929 | 349.604 | 0 | 35.297 |
| Nettowijziging in Geldmiddelen | -44.889 | -65.63 | 150.885 | -24.631 | -1.683 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -20.724 | -101.945 | -76.534 | -51.899 | -24.528 |
| Cash From Operating Activities | -26.461 | -94.498 | -70.657 | -42.593 | -26.277 |
| Cash From Operating Activities | 1.014 | 3.073 | 2.068 | 1.134 | 0.472 |
| Non-Cash Items | 1.555 | 8.838 | 7.268 | 4.983 | 2.559 |
| Changes in Working Capital | -8.306 | -4.464 | -3.459 | 3.189 | -4.78 |
| Cash From Investing Activities | 45.125 | 49.438 | 17.976 | -11.949 | -15.382 |
| Capital Expenditures | -0.075 | -11.614 | -10.921 | -10.171 | -2.488 |
| Other Investing Cash Flow Items, Total | 45.2 | 61.052 | 28.897 | -1.778 | -12.894 |
| Cash From Financing Activities | 0 | 0.171 | 0.171 | 0.144 | 0.134 |
| Issuance (Retirement) of Stock, Net | 0.039 | 0.171 | 0.171 | 0.144 | 0.134 |
| Net Change in Cash | 18.664 | -44.889 | -52.51 | -54.398 | -41.525 |
| Financing Cash Flow Items | -0.039 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| Fidelity Management & Research Company LLC | Investment Advisor | 14.9917 | 6367180 | 8776 | 2023-03-31 | LOW |
| Redmile Group, LLC | Investment Advisor/Hedge Fund | 13.2323 | 5619914 | 0 | 2023-03-31 | LOW |
| Hornblower Capital Holdings, LLC | Corporation | 6.809 | 2891853 | -419856 | 2022-12-08 | |
| Houghton Capital Holdings, LLC | Corporation | 6.1471 | 2610750 | 0 | 2023-03-01 | LOW |
| Millennium Pharmaceuticals Inc | Corporation | 4.923 | 2090858 | -9454 | 2021-12-31 | |
| Prosight Capital | Hedge Fund | 4.7601 | 2021668 | -91825 | 2023-03-31 | |
| The Clark Estates Inc. | Investment Advisor | 3.4745 | 1475648 | -4750 | 2023-03-31 | MED |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.7669 | 1175121 | 11040 | 2023-03-31 | LOW |
| Investment Management of Virginia, L.L.C. | Investment Advisor | 1.1915 | 506040 | 87200 | 2023-03-31 | LOW |
| Laurion Capital Management LP | Hedge Fund | 1.1914 | 506000 | 0 | 2023-03-31 | HIGH |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.0895 | 462711 | 1493 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8151 | 346185 | 0 | 2023-03-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.5843 | 248167 | -8133 | 2023-03-31 | HIGH |
| Brous (Tyler) | Individual Investor | 0.5408 | 229672 | 0 | 2023-03-01 | LOW |
| Neill (Andrew R.) | Individual Investor | 0.34 | 144416 | 34925 | 2023-01-25 | |
| Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 0.2898 | 123086 | -15190 | 2023-03-31 | MED |
| Pathstone | Investment Advisor | 0.2716 | 115339 | 0 | 2023-03-31 | MED |
| Pandite (Arundathy N.) | Individual Investor | 0.2634 | 111864 | -63928 | 2023-03-01 | LOW |
| Ritholtz Wealth Management LLC | Investment Advisor | 0.2557 | 108615 | 0 | 2023-03-31 | HIGH |
| Thomson (Erin Ator) | Individual Investor | 0.243 | 103209 | 24125 | 2023-01-25 |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group530K+
Handelaren
87K+
Actieve klanten per maand
$46M+
Maandelijks beleggingsvolume
$31M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Shattuck Labs, Inc. Company profile
Over Shattuck Labs, Inc.
Shattuck Labs, Inc. is een biotechnologiebedrijf in een klinische fase. Het bedrijf houdt zich bezig met de ontwikkeling van dubbelzijdige fusie-eiwitten. Het bedrijf heeft een benadering voor immuunmodulatie gecreëerd door biologische geneesmiddelen met structurele kenmerken te ontwerpen. Samenstellingen afgeleid van zijn Agonist Redirected Checkpoint (ARC) platform remmen tegelijkertijd checkpointmoleculen en activeren costimulatoire moleculen binnen één enkel therapeutisch middel. De voornaamste kandidaat-geneesmiddel, SL-172154, is ontworpen om tegelijkertijd de interactie tussen het controlepunt en de cluster van differentiatie 47/signal regulatory protein alpha (CD47/SIRPa) te remmen om een immuunrespons tegen tumoren te herstellen en de costimulatoire receptor van de cluster van differentiatie 40 (CD40) te activeren om de immuunrespons te versterken. De tweede productkandidaat van de Vennootschap, SL-279252, is ontworpen om tegelijkertijd de geprogrammeerde-dood-1/geprogrammeerde-dood-ligand 1 (PD-1/PD-L1) interactie af te remmen en de OX40-receptor te activeren.
| Industry: | Biotechnology & Medical Research (NEC) |
500 W. 5Th Street
Suite 100
AUSTIN
TEXAS 78701
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 530.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen